[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100596322":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":31,"centralContacts":35,"locations":42,"responsibleParty":215,"collaborators":40,"id":217,"slug":218,"hasResults":219,"nctId":220,"briefTitle":221,"officialTitle":222,"acronym":40,"eligibilityCriteria":223,"healthyVolunteers":219,"sex":224,"minAge":225,"maxAge":40,"enrollmentInfo":226,"targetDuration":40,"studyType":229,"phases":230,"briefSummary":233,"conditions":234,"keywords":40,"overallStatus":45,"whyStopped":40,"lastUpdateSubmitDate":240,"lastUpdatePostDateStruct":241,"startDateStruct":244,"completionDateStruct":246,"leadSponsor":248,"locationsCount":249},{"fullName":5,"class":6},"Climb Bio, Inc.","INDUSTRY",[8,14,17,20],{"label":9,"type":10,"description":11,"interventionNames":12},"Cohort 1: Dose Level A","EXPERIMENTAL","Single IV dose of study product on Day 1 and on Day 15",[13],"Drug: Budoprutug",{"label":15,"type":10,"description":11,"interventionNames":16},"Cohort 2: Dose Level B",[13],{"label":18,"type":10,"description":11,"interventionNames":19},"Cohort 3: Dose Level C",[13],{"label":21,"type":10,"description":22,"interventionNames":23},"Dose Expansion Cohort","Single IV dose of study product on Day 1 and Day 15",[13],[25],{"type":26,"name":27,"description":22,"armGroupLabels":28,"otherNames":29},"DRUG","Budoprutug",[9,15,18,21],[30],"TNT119",[32],{"name":33,"affiliation":5,"role":34},"Study Director","STUDY_DIRECTOR",[36],{"name":37,"role":38,"phone":39,"phoneExt":40,"email":41},"Climb Bio Study Director","CONTACT","+1 866 857 2596",null,"clinicaltrials@climbbio.com",[43,56,62,71,83,92,101,110,120,125,133,145,154,162,171,181,189,197,202,207],{"facility":44,"status":45,"city":46,"state":40,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":40},"Climb Bio Investigative Site #359202","RECRUITING","Plovdiv","4002","Bulgaria","BG",{"type":51,"coordinates":52},"Point",[53,54],24.75001,42.15387,{"lat":54,"lon":53},{"facility":57,"status":45,"city":46,"state":40,"zip":58,"country":48,"countryCode":49,"cosmosGeoPoint":59,"geoPoint":61,"contacts":40},"Climb Bio Investigative Site #359203","4003",{"type":51,"coordinates":60},[53,54],{"lat":54,"lon":53},{"facility":63,"status":45,"city":64,"state":40,"zip":65,"country":48,"countryCode":49,"cosmosGeoPoint":66,"geoPoint":70,"contacts":40},"Climb Bio Investigative Site #359201","Sofia","1797",{"type":51,"coordinates":67},[68,69],23.32415,42.69751,{"lat":69,"lon":68},{"facility":72,"status":45,"city":73,"state":74,"zip":75,"country":76,"countryCode":77,"cosmosGeoPoint":78,"geoPoint":82,"contacts":40},"Climb Bio Investigative Site #300204","Athens","Attica","11527","Greece","GR",{"type":51,"coordinates":79},[80,81],23.72784,37.98376,{"lat":81,"lon":80},{"facility":84,"status":45,"city":85,"state":74,"zip":86,"country":76,"countryCode":77,"cosmosGeoPoint":87,"geoPoint":91,"contacts":40},"Climb Bio Investigative Site #300203","Chaïdári","12462",{"type":51,"coordinates":88},[89,90],23.66597,38.01135,{"lat":90,"lon":89},{"facility":93,"status":45,"city":94,"state":40,"zip":95,"country":76,"countryCode":77,"cosmosGeoPoint":96,"geoPoint":100,"contacts":40},"Climb Bio Investigative Site #300202","Ioannina","45500",{"type":51,"coordinates":97},[98,99],20.85187,39.66341,{"lat":99,"lon":98},{"facility":102,"status":45,"city":103,"state":40,"zip":104,"country":76,"countryCode":77,"cosmosGeoPoint":105,"geoPoint":109,"contacts":40},"Climb Bio Investigative Site #300201","Thessaloniki","57010",{"type":51,"coordinates":106},[107,108],22.93493,40.64072,{"lat":108,"lon":107},{"facility":111,"status":45,"city":112,"state":40,"zip":40,"country":113,"countryCode":114,"cosmosGeoPoint":115,"geoPoint":119,"contacts":40},"Climb Bio Investigative Site #381201","Belgrade","Serbia","RS",{"type":51,"coordinates":116},[117,118],20.46513,44.80401,{"lat":118,"lon":117},{"facility":121,"status":45,"city":112,"state":40,"zip":40,"country":113,"countryCode":114,"cosmosGeoPoint":122,"geoPoint":124,"contacts":40},"Climb Bio Investigative Site #381202",{"type":51,"coordinates":123},[117,118],{"lat":118,"lon":117},{"facility":126,"status":45,"city":127,"state":40,"zip":40,"country":113,"countryCode":114,"cosmosGeoPoint":128,"geoPoint":132,"contacts":40},"Climb Bio Investigative Site #381203","Novi Sad",{"type":51,"coordinates":129},[130,131],19.83694,45.25167,{"lat":131,"lon":130},{"facility":134,"status":135,"city":136,"state":40,"zip":137,"country":138,"countryCode":139,"cosmosGeoPoint":140,"geoPoint":144,"contacts":40},"Climb Bio Investigative Site #340206","NOT_YET_RECRUITING","Burgos","9006","Spain","ES",{"type":51,"coordinates":141},[142,143],-3.70184,42.34106,{"lat":143,"lon":142},{"facility":146,"status":45,"city":147,"state":40,"zip":148,"country":138,"countryCode":139,"cosmosGeoPoint":149,"geoPoint":153,"contacts":40},"Climb Bio Investigative Site #340204","Madrid","28041",{"type":51,"coordinates":150},[151,152],-3.70256,40.4165,{"lat":152,"lon":151},{"facility":155,"status":45,"city":156,"state":40,"zip":40,"country":138,"countryCode":139,"cosmosGeoPoint":157,"geoPoint":161,"contacts":40},"Climb Bio Investigative Site #340202","San Pedro",{"type":51,"coordinates":158},[159,160],-4.99123,36.48839,{"lat":160,"lon":159},{"facility":163,"status":45,"city":164,"state":40,"zip":165,"country":138,"countryCode":139,"cosmosGeoPoint":166,"geoPoint":170,"contacts":40},"Climb Bio Investigative Site #340203","Valencia","46010",{"type":51,"coordinates":167},[168,169],-0.37966,39.47391,{"lat":169,"lon":168},{"facility":172,"status":135,"city":173,"state":40,"zip":40,"country":174,"countryCode":175,"cosmosGeoPoint":176,"geoPoint":180,"contacts":40},"Climb Bio Investigative Site #380208","Cherkasy","Ukraine","UA",{"type":51,"coordinates":177},[178,179],32.05738,49.44452,{"lat":179,"lon":178},{"facility":182,"status":45,"city":183,"state":40,"zip":40,"country":174,"countryCode":175,"cosmosGeoPoint":184,"geoPoint":188,"contacts":40},"Climb Investigative Site #380204","Ivano-Frankivsk",{"type":51,"coordinates":185},[186,187],24.71248,48.92312,{"lat":187,"lon":186},{"facility":190,"status":45,"city":191,"state":40,"zip":40,"country":174,"countryCode":175,"cosmosGeoPoint":192,"geoPoint":196,"contacts":40},"Climb Investigative Site #2380203","Kyiv",{"type":51,"coordinates":193},[194,195],30.5238,50.45466,{"lat":195,"lon":194},{"facility":198,"status":45,"city":191,"state":40,"zip":40,"country":174,"countryCode":175,"cosmosGeoPoint":199,"geoPoint":201,"contacts":40},"Climb Investigative Site #380202",{"type":51,"coordinates":200},[194,195],{"lat":195,"lon":194},{"facility":203,"status":45,"city":191,"state":40,"zip":40,"country":174,"countryCode":175,"cosmosGeoPoint":204,"geoPoint":206,"contacts":40},"Climb Investigative Site #380206",{"type":51,"coordinates":205},[194,195],{"lat":195,"lon":194},{"facility":208,"status":45,"city":209,"state":40,"zip":40,"country":174,"countryCode":175,"cosmosGeoPoint":210,"geoPoint":214,"contacts":40},"Climb Investigative Site #380201","Lviv",{"type":51,"coordinates":211},[212,213],24.02324,49.83826,{"lat":213,"lon":212},{"type":216,"investigatorFullName":40,"investigatorTitle":40,"investigatorAffiliation":40,"oldNameTitle":40,"oldOrganization":40},"SPONSOR","100596322","phase-1-a-phase-1b2a-study-of-budoprutug-in-subjects-with-immune-thrombocytopenia-itp-100596322",false,"NCT07043946","A Phase 1b\u002F2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)","A Phase 1b\u002F2a, Open-Label, Sequential-Cohort, Dose Escalation and Expansion Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Clinical Effectiveness of Budoprutug (TNT119) in Subjects With Immune Thrombocytopenia (ITP)","Inclusion Criteria:\n\n1. Aged 18 years at the time of consent.\n2. Platelet count \\\u003C 30,000\u002FµL despite an adequate trial of at least one prior therapeutic attempt. Platelet counts of \\\u003C 30,000\u002FµL must be confirmed on 2 occasions at least 5 days apart, but no more than 14 days apart.\n3. Partial thromboplastin time \\\u003C 1.5 x upper limit of normal (ULN), prothrombin time \\\u003C 1.5 x ULN, total bilirubin \\\u003C 1.5 x ULN unless due to Gilbert's syndrome, or an international normalized ratio \\\u003C 1.5 at screening.\n\nExclusion Criteria:\n\n1. CD19+ B cell count \\\u003C 80 cells\u002FµL at Screening, or \\\u003C 40 cells\u002FµL if B-cell depleting therapy was received within 24 weeks to 2 years prior.\n2. Diagnosis of paroxysmal nocturnal hemoglobinuria, Evan's Syndrome, or other bleeding disorders affecting safety or data integrity.\n3. Prior B-cell depleting therapy (e.g., rituximab) within 24 weeks before first dose or planned during the study.\n4. Chronic use of anticoagulants or antiplatelet agents (e.g., aspirin, NSAIDs, thienopyridines) within 14 days before dosing through follow-up. Intermittent NSAID use is allowed.\n5. Immunosuppressants (excluding corticosteroids) within 30 days or 5× half-life before Screening; alkylating agents within 180 days.\n6. IVIg treatment within 90 days prior to Screening.\n7. Active ITP treatment (other than steroids or TPO agonists) within 30 days or 5× half-life before first dose, unless approved by Medical Monitor.\n8. Active, chronic, or latent infections including hepatitis B\u002FC or HIV.\n9. Active TB or high TB risk.","ALL","18 Years",{"count":227,"type":228},24,"ESTIMATED","INTERVENTIONAL",[231,232],"PHASE1","PHASE2","The main objective is to assess the safety and tolerability of budoprutug in adults with ITP. Pharmacokinetics, pharmacodynamics, and preliminary clinical efficacy will also be assessed.",[235,236,237,238,239],"Immune Thrombocytopenia (ITP)","ITP","Biologics","Monoclonal","Anti-CD19","2026-03-24",{"date":242,"type":243},"2026-03-27","ACTUAL",{"date":245,"type":243},"2025-06-30",{"date":247,"type":228},"2028-08",{"name":5,"class":6},20]